title: Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.
abstract: Acute leukopenia occurs in all patients during the first hour of hemodialysis with cellophanemembrane equipment. This transient cytopenia specifically involves granulocytes and monocytes, cells which share plasma membrane reactivity towards activated complement components. The present studies document that complement is activated during exposure of plasma to dialyzer cellophane, and that upon reinfusion of this plasma into the venous circulation, granulocyte and monocyte entrapment in the pulmonary vasculature is induced. During early dialysis, conversion of both C3 and factor B can be demonstrated in plasma as it leaves the dialyzer. Moreover, simple incubation of human plasma with dialyzer cellophane causes conversion of C3 and factor B, accompanied by depletion of total hemolytic complement and C3 but sparing of hemolytic C1. Reinfusion of autologous, cellophane-incubated plasma into rabbits produces selective granulocytopenia and monocytopenia identical to that seen in dialyzed patients. Lungs from such animals reveal striking pulmonary vessel engorgement with granulocytes. The activated complement component(s) responsible for leukostasis has an approximate molecular weight of 7,000-20,000 daltons. Since it is generated in C2-deficient plasma and is associated with factor B conversion, it is suggested that activation of complement by dialysis is predominantly through the altermative pathway.
mesh_terms: D000328:Adult; D000818:Animals; D001772:Blood Cell Count; D002476:Cellophane / Q000009:adverse effects*; D003165:Complement System Proteins / Q000502:physiology*; D006098:Granulocytes; D006801:Humans; D007957:Leukocyte Adherence Inhibition Test; D007970:Leukopenia / Q000209:etiology*; D008168:Lung / Q000098:blood supply; D011817:Rabbits; D006435:Renal Dialysis / Q000009:adverse effects*; D015054:Zymosan / Q000009:adverse effects
chemical_list: D002476:Cellophane; D003165:Complement System Proteins; D015054:Zymosan